These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2018-004269-14 Loss of RESponse to Ustekinumab treated by dose Escalation Verlies van respons op ustekinumab behandeld via dosis escalatie Perte de réponse à l’ustékinumab traitée par augmentation de la dose. not-yet-due
Ongoing 2021-000345-41 An Open-Label Extension and long-term efficacy and safety monitoring study of patients with Crohn’s disease previously included in the loss of RESponse to Ustekinumab treated by dose Escalation study ... not-yet-due